Omnicell (OMCL) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts OMCL Hot Sheet
Price: $27.13 -1.09%
Revenue Growth %: -18.6%
Financial Fact:
Selling, general and administrative: 61.32M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: -18.6%
Financial Fact:
Selling, general and administrative: 61.32M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Omnicell (NASDAQ: OMCL) reported Q3 EPS of $0.30, $0.01 worse than the analyst estimate of $0.31. Revenue for the quarter came in at $112.5 million versus the consensus estimate of $106.1 million.
For earnings history and earnings-related data on Omnicell (OMCL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Arca Biopharma (ABIO) Reports Q1 Loss of $0.14
- Byline Bancorp (BY) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
